Stories Tagged: pharmaceuticals

🤷🤷🤷
Investment Opportunities in Drug Stocks: Talaria Capital Tips Roche for 35% Jump

In the ever-evolving financial markets, investment opportunities arise in various sectors.... (2 revisions)

🤷🤷🤷
EU Investigates AliExpress for Selling Counterfeit Drugs, Police Step Up Efforts to Stop Illegal Sale of Pills

Pharmaceutical manufacturer Eli Lilly has filed a complaint with the US International Trade... (3 revisions)

🤷🤷🤷
Miami-Dade Mayor Visits Japan to Enhance Investment and Trade for South Florida

Miami-Dade Mayor Daniella Levine Cava is currently on a visit to Japan to promote investment and... (3 revisions)

🤷🤷🤷
ANI Pharmaceuticals and Enanta Pharmaceuticals: A Tale of Two Pharmaceutical Companies

ANI Pharmaceuticals Inc. is a shining example of innovation and success in the pharmaceutical... (4 revisions)

🤷🤷🤷
Port of Cork Enhances Trade Links with Indiana through New MoU

The Port of Cork Company (PoCC) has taken a significant step in strengthening its trade ties... (5 revisions)

🤷🤷🤷
AAR Healthcare Expands with New Outpatient Centre in Kamakis, Kenya

FarmaKeio Custom Compounding, a pharmaceutical company based in Richardson, Texas, has acquired... (6 revisions)

🤷🤷🤷
Boosting U.S.-Brazil Health and Trade Cooperation

In a pivotal moment for U.S.-Brazil relations, strengthening the Brazilian Health Regulatory... (8 revisions)

🤷🤷🤷
Ozempic: A Game Changer in Addiction and Chronic Disease Treatment?

Ozempic, a diabetes treatment known for its ability to manage blood sugar levels and promote... (9 revisions)

🤷🤷🤷
Hong Kong's New Drug-Approval Agency: A Step Towards Healthcare Innovation

In a significant move to enhance healthcare innovation, Hong Kong plans to establish the Hong... (9 revisions)

🤷🤷🤷
Ateco Pharma Egypt Seeks Collaboration with US Embassy for Export Growth

Ateco Pharma Egypt hosted a delegation from the US Embassy on December 14, 2024, to explore... (9 revisions)

🤷🤷🤷
Daré Bioscience Reports Q4 2023 Earnings and Updates on Women's Health Product Development

Daré Bioscience, Inc. (NASDAQ:DARE) reported its Q4 2023 earnings, surpassing expectations with... (11 revisions)

🤷🤷🤷
Investment Firms Adjust Holdings in Oaktree Specialty Lending, The Oncology Institute, A. O. Smith Co., Omnicom Group Inc., and GSK plc

Greenwich Investment Management Inc., a financial management company, has reduced its holdings... (11 revisions)

🤷🤷🤷
GSK to Pay £1.7bn to Settle Tens of Thousands of Zantac Lawsuits

GlaxoSmithKline (GSK) has reached a significant settlement agreement to pay up to $2.2 billion... (16 revisions)

🤷🤷🤷
Sanofi's Opella Sale: Balancing Investment and National Concerns

The planned sale of Doliprane, France's best-selling painkiller, to US investors has ignited a... (20 revisions)

🤷🤷🤷
Can Nigeria Secure $20 Billion Annually for Economic Growth?

On December 21, 2024, Wale Edun, Nigeria's Minister of Finance, reiterated the urgent need for... (20 revisions)

🤷🤷🤷
Britain Chooses Pfizer Over GSK for RSV Vaccine

Antibiotic-resistant infections continue to pose a significant threat, but recent breakthroughs... (22 revisions)

🤷🤷🤷
Mixed Reactions to President Biden's State of the Union Address and Fashion Choices

President Joe Biden delivered his final State of the Union address on March 7, 2024. The address... (25 revisions)

🤷🤷🤷
Switzerland's Balancing Act: Navigating Trade Between China and the US

Switzerland finds itself in a precarious position as it navigates the complex geopolitical... (28 revisions)

🤷🤷🤷
India's Finance Minister Proposes Bharat FDA for Global Pharmaceutical Standards

During the 8th India Ideas Conclave held on November 23, 2024, in Bengaluru, Union Finance... (30 revisions)

🤷🤷🤷
Mark Cuban Critiques US Healthcare System Amid Political Tensions

In a recent statement, billionaire entrepreneur Mark Cuban expressed his deep concerns regarding... (90 revisions)